UNSPSC 51401526: Flunitrazepam

This classification denotes a benzodiazepine with the molecular formula C16H12FN3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 620X0222FQ, chemically known as 1,3-dihydro-5-(o-fluorophenyl)-1-methyl-7-nitro-2h-1,4-benzodiazepin-2-one but generally known as flunitrazepam, which bears US NIH Compound Identifier 3380. European Medicines Agency schedules Flunitrazepam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07710MIG.

UNSPSC 51401526 Flunitrazepam, a Commodity code, shows minimal recent state and local procurement activity aligned with its nominal scope. The single recent opportunity in the dataset — Seminole County, Florida's IFB 60459723LAS posted June 30, 2026 — solicits naloxone and safe drug deactivation systems rather than flunitrazepam itself, indicating a significant mismatch between the code assignment and the work actually being bought. State and local governments do not appear to be actively procuring flunitrazepam through routine solicitations; the code remains dormant or poorly aligned with real purchasing patterns in the state and local market.

Seminole County's naloxone procurement (IFB, due July 26, 2023) sought 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The contract carried a two-year initial term with a one-year renewal option, included E-Verify and drug-free workplace requirements, and referenced potential FEMA funding. No other state or local jurisdictions appear in the recent-opportunities dataset under this code. Given the absence of relevant flunitrazepam solicitations and the code's apparent misapplication to opioid-antagonist procurement, this code does not present a current business development opportunity for vendors focused on controlled-substance products or pharmaceutical supply chains.